Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research; Amended Notice of Meeting, 68671 [2021-26298]

Download as PDF Federal Register / Vol. 86, No. 230 / Friday, December 3, 2021 / Notices Order and does not modify its terms in any way. DEPARTMENT OF HEALTH AND HUMAN SERVICES By direction of the Commission. April J. Tabor, Secretary. Centers for Disease Control and Prevention [FR Doc. 2021–26294 Filed 12–2–21; 8:45 am] Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS) BILLING CODE 6750–01–P Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention jspears on DSK121TN23PROD with NOTICES1 Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– CK–22–003, Emerging Infections Sentinel Networks (EISN) Research; January 11, 2022, 10:00 a.m.–5:00 p.m., EST, Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Boulevard, Atlanta, Georgia 30329–4027, in the original FRN. The meeting was published in the Federal Register on November 8, 2021, Volume 86, Number 213, page 61767. The meeting is being amended to change the contact information and should read as follows: FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329–4027, Telephone: (404) 718–8833; Email: GAnderson@cdc.gov. The meeting is closed to the public. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–26298 Filed 12–2–21; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 18:06 Dec 02, 2021 Jkt 256001 In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). This meeting is open to the public. DATES: The meeting will be held on February 10, 2022, from 11:00 a.m. to 5:15 p.m., EST (times subject to change). ADDRESSES: Instructions to access the meeting are posted here: https:// www.cdc.gov/nchs/about/bsc/bsc_ meetings.htm. SUMMARY: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CK–22– 003, Emerging Infections Sentinel Networks (EISN) Research; Amended Notice of Meeting 68671 are subject to change as priorities dictate. Meeting Information: Please visit the BSC website for details: https:// www.cdc.gov/nchs/about/bsc/bsc_ meetings.htm for more information on the meeting agenda, including instructions for accessing the live meeting broadcast. The Board will reserve time for public comment at the end of the day. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–26317 Filed 12–2–21; 8:45 am] BILLING CODE 4163–18–P FOR FURTHER INFORMATION CONTACT: Rebecca Hines, M.H.S., Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 Toledo Road, Room 2627, Hyattsville, Maryland 20782, Telephone: (301) 458–4717; Email: RSHines@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Board is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters to be Considered: The meeting agenda will include welcome remarks and a Center update by the NCHS Director; a welcome and introductions for five new Board members who will be attending their first BSC meeting; discussion with members on plans and potential revisions to NCHS surveys, including the addition of new questions; a report out from the Population Health Survey Planning, Methodology and Data Presentation (PHSPMDP) Workgroup on their assessment of the use of panel survey data by NCHS; an update on approaches to enhancing identification of opioid-Involved hospitalizations with clinical data and notes from electronic health records, and; an update on several NCHS Programs. Agenda items PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [OMB No. 0970–0167] Proposed Information Collection Activity; ACF–801: Child Care and Development Fund (CCDF) Quarterly Case-Level Report Office of Child Care, Administration for Children and Families, HHS. ACTION: Request for public comment. AGENCY: The Office of Child Care (OCC), Administration for Children and Families (ACF) is requesting a 3-year extension of the form ACF–801: CCDF Quarterly Case-Level Report (OMB #0970–0167, expiration 2/28/2022). OCC proposes minor changes to the response categories under the following three data elements: Child’s gender, ethnicity, and race. DATES: Comments due within 60 days of publication. In compliance with the requirements of the Paperwork Reduction Act of 1995, ACF is soliciting public comment on the specific aspects of the information collection described above. SUMMARY: E:\FR\FM\03DEN1.SGM 03DEN1

Agencies

[Federal Register Volume 86, Number 230 (Friday, December 3, 2021)]
[Notices]
[Page 68671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26298]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-CK-22-003, Emerging Infections Sentinel 
Networks (EISN) Research; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) 
Research; January 11, 2022, 10:00 a.m.-5:00 p.m., EST, Teleconference, 
Centers for Disease Control and Prevention, Room 1080, 8 Corporate 
Square Boulevard, Atlanta, Georgia 30329-4027, in the original FRN. The 
meeting was published in the Federal Register on November 8, 2021, 
Volume 86, Number 213, page 61767.
    The meeting is being amended to change the contact information and 
should read as follows:

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027, Telephone: (404) 718-8833; Email: 
[email protected].
    The meeting is closed to the public.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-26298 Filed 12-2-21; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.